The Sleeping Beast: Tackling Diseases in their Dormant Stages

Swiss TPH Symposium

Persistent or dormant stages present an obstacle in the therapy and elimination of diseases such as malaria, Chagas disease, leishmaniasis, tuberculosis, other bacterial infections, and cancer. Join a diverse mix of specialists and students for a mutual learning event on overcoming the challenges of dormant, 'persister' stages of pathogens. The event will cover:

  • signaling mechanisms and host-pathogen interaction
  • treatment options (molecules that kill dormant stages or wake them up)
  • disease control and elimination programs

08:30 On-site Registration

(08:55 virtual check-in)

Moderator: Sebastien Gagneaux, Swiss TPH
09:00Welcome and Setting the Stage, Pascal Mäser, Swiss TPH
09:20Persister-Like Cells in Parasitic Protozoa: How and Why?, Michael Barrett, University of Glasgow
09:50Bacterial Drug Tolerance and Persisters, Dirk Bumann, Biozentrum, University of Basel 
10:20Can We Keep Cancer Asleep?, Ana Luísa Correia, Foundation Champalimaud Lisbon (virtual)
10:40Coffee Break (30 minutes)

Moderator: Pascal Mäser, Swiss TPH
11:10Antibiotic Lethality Drives Mycobacterial Infection Outcomes, Lucas Boeck, University of Basel
11:25The Double Face of Persistence in Kinetoplastids, Lara Lopez Escobar, Institute of Tropical Medicine Antwerp
11:40Know Thy Enemy: Diving into the World of Malaria Hypnozoites, Anne-Marie Zeeman, Biomedical Primate Research Centre, the Netherlands
11:55The Sleeper Takes It All: Transient and Slowed Down Forms of Trypanosoma cruzi, Francisco Olmo, London School of Hygiene and Tropical Medicine and University of Granada
12:10From Signaling Networks to Tissue Ecosystems: Imaging Cancer Cell Persistence, Olivier Pertz, University of Bern
12:25Lunch (60 minutes)

Moderator: Francisco Olmo, LSHTM and University of Granada
13:25Sleeping Beauties: Quiescence in P. falciparum Gametocytes, Leonie Seefeldt, Swiss TPH
13:30Studying Leishmania Persisters in Macrophages, Malenka Kunz, Swiss TPH
13:35Persistence in Pseudomonas Aeruginosa, Pablo Manfredi, University of Basel Biozentrum
13:40Investigating the Link Between Phenotypic Drug Tolerance and Drug Resistance Amplification in Mycobacterium Tuberculosis, Kakha Mchedlishvili, Swiss TPH
13:45Mycobacterium Tuberculosis in Hostile Host Environments: Persistence Through Dormancy?, Sarah Schmidiger, Swiss TPH
13:50Patient-Specific Characterization of Drug Refractory Metastatic Lesions by Functional Drug Screening and Imaging Mass Cytometry, Charly Jehanno, University Hospital Basel
13:55Quick Break (10 minutes)

Moderator: Patricia Bravo, Swiss TPH
14:05Mycobacteria Persisters in Disease Control, Dorothy Yeboah–Manu, Noguchi Memorial Institute for Medical Research, University of Ghana
14:35P. vivax Hypnozoites Therapy and Management - Is There Hope for Elimination?, Moses Laman, Papua New Guinea Institute of Medical Research 
15:50The Probability of Plasmodium vivax Acute Illness Following Primary Infection and Relapse in Papua New Guinea, Amanda Ross, Swiss TPH
15:05The Health Authorities Perspective on Persisters, Marcus Lacerda, World Health Organization (virtual)
15:25Coffee Break (35 minutes) 

Moderator: Lisabeth Reus, Swiss TPH
16:00Panel Discussion
 
  • Michael Barrett, University of Glasgow
  • Dirk Bumann, University of Basel Biozentrum
  • Dorothy Yeboah–Manu, Noguchi Memorial Institute for Medical Research, Ghana
  • Moses Laman, Papua New Guinea Institute of Medical Research
  • Malgorzata Domagalska, Institute of Tropical Medicine Antwerp
  • Olivier Pertz, University of Bern
16:50Closing Words, Jürg Utzinger, Director, Swiss TPH
17:00End of Day

Information

When and where

Date4 June 2026
Time09:00- 17:00 CEST
VenueSwiss TPH
Kreuzstrasse 2
4123 Allschwil
Switzerland

 

{"locations":{"0":{"title":"Swiss TPH, Kreuzstrasse 2, 4123 Allschwil","description":"<p><\/p>","latitude":"47.55979","longitude":"7.55064","projects":{}}}}
Selected projects at this location: